A growing number of pharma companies have been investing in continuous manufacturing because of the cost and time advantages of producing small-molecule drugs. (Steven Depolo) () CDMO Cambrex, an ...

The company Debut Bio has announced their seed funding of $2.6 million, with KdT Ventures leading. The round was oversubscribed and included participation from Better Ventures, FTW Ventures, and ...

An API capacity expansion at the Cambrex site in Karlskoga, Sweden includes continuous manufacturing technology. (Cambrex) () CDMO Cambrex has decided to be an early adopter of continuous flow ...

WEST LAFAYETTE, Ind. – The COVID-19 pandemic has created supply chain gaps in critical drug products, especially those needed for the most critical patients in intensive care units across the country.

The FDA recognises the value of continuous manufacturing and is working to raise the level of awareness of this technology amongst its review staff. As one initiative the 1st CONTINUOUS MANUFACTURING ...

RICHMOND, Va.--(BUSINESS WIRE)--Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) today announced a strategic alliance to develop a new ...

Several industry trade associations are asking for more clarity on the International Council for Harmonisation’s (ICH) Q13 guideline on continuous manufacturing, including what constitutes a state of ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Continuous Manufacturing Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's ...

Discover how bioprocessing technology industrial applications expand as fermentation, membrane filtration, PAT, and ...